Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Status:
Completed
Trial end date:
2010-04-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether there is a drug interaction between
GSK1349572 and the HIV protease inhibitors Tipranavir/Ritonavir (TPV/RTV).